Src kinase-dependent epidermal growth factor receptor transactivation in PPARγ ligand-induced suppression of Porphyromonas gingivalis interference with salivary mucin synthesis

IUBMB Life

Volumn 56, Issue 3, 2004, Pages 153-159

  Slomiany, Bronislaw L ^a,b   Slomiany, Amalia ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

EGFR transactivation; P. gingivalis LPS; PI3K; PPAR ; Salivary mucin

Indexed keywords

4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; CASPASE 3; CIGLITAZONE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; LIGAND; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MUCIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 2; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG; WORTMANNIN;

APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; NONHUMAN; PORPHYROMONAS GINGIVALIS; PROTEIN FUNCTION; PROTEIN SYNTHESIS; TRANSACTIVATION; UPREGULATION;

ANIMALS; HYPOGLYCEMIC AGENTS; LIPOPOLYSACCHARIDES; MUCINS; PORPHYROMONAS GINGIVALIS; PPAR GAMMA; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SALIVARY GLANDS; SRC-FAMILY KINASES; THIAZOLIDINEDIONES; TRANS-ACTIVATION (GENETICS);

NEGIBACTERIA; PORPHYROMONAS; PORPHYROMONAS GINGIVALIS;

EID: 2442706630     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/15216540410001690456     Document Type: Article

References (19)

1. Wang, N., Verna, L., Chen, N. G., Chen, J., Li, H., Forman, B. M., and Stemerman, M. B. (2002) Constitutive activation of peroxisome proliferator-activated receptor-γ suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells. J. Biol. Chem. 277, 34176-34181.
2. Dowell, P., Otto, T. C., Adi, S., and Lane, M. D. (2003) Convergence of peroxisome proliferator-activated receptor γ and Foxol signaling pathways. J. Biol. Chem. 278, 45485-45491.
3. Inoue, H., Tanabe, T., and Umesone, K. (2000) Feedback control of cyclo- oxygenase expression through PPARγ. J. Biol. Chem. 275, 28028-28032.
4. Slomiany, B. L., and Slomiany, A. (2003) Activation of PPARγ suppresses inducible cyclooxygenase and nitric oxide synthase during oral mucosal ulcer healing. J. Physiol. Pharmacol. 53, 159-169.
5. Nakajima, A., Wada, K., Miki, H., Kubota, N., Nakajima, Y., Terauchi, Y., Ohnishi, S., Saubermann, L. J., Kadowak, T., Blumberg, R. S., et al. (2001) Endogenous PPARγ mediates antiinflammatory activity in murine ischemia-reperfusion injury. Gastroenterology 120, 460-469.
6. Teruel, T., Hernandez, R., Benito, M., and Lorenzo, M. (2003) Rosiglitazone and retinoic acid induce uncoupling protein-1 (UCP-1) in p38 mitogen-activated protein kinase-dependent manner in fetal primary brown adipocytes. J. Biol. Chem. 278, 263-269.
7. Garner, O. S., Dewar, B. J., Earp, H. S., Samet, J. M., and Graves, L. M. (2003) Dependence of peroxisome proliferator-activated receptor ligand-induced mitogen-activated protein kinase signaling on epidermal growth factor transactivation. J. Biol. Chem. 278, 46261-46269.
8. 2 and thiazolidinediones activate the MEK/ERK pathway through PI3-kinase in vascular smooth muscle cells. J. Biol. Chem. 276, 48950-48955.
9. Slomiany, B. L., and Slomiany, A. (2003) Activation of peroxisome proliferator-activated receptor γ impedes Porphyromonas gingivalis lipopolysaccharide interference with salivary mucin synthesis through phosphatidylinositol 3-kinase/ERK pathway. J. Physiol. Pharmacol. 54, 3-15.
10. Haynes, M. P., Li, L., Sinha, D., Russell, K. S., Hisamoto, K., Baron, R., Collinge, R. M., Sessa, W. C., and Bender, J. R. (2003) Src kinase mediates phosphatidylinositol 3-kinase/Akt dependent rapid endothelial nitric-oxide synthase activation by estrogen. J. Biol. Chem. 278, 2118-2123.
11. Guha, M., and Mackman, M. N. (2002) The phosphatidylinositol 3-kinase-Akt pathway inhibits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J. Biol. Chem. 277, 32124-32132.
12. Carpenter, G. (1999) Employment of the epidermal growth factor receptor in growth factor-independent signaling pathways. J. Cell Biol. 146, 697-702.
13. Shah, B. H., Farshori, M. P., Jambusaria, A., and Catt, K. J. (2003) Roles of Src and epidermal growth factor receptor transactivation in transient and sustained ERK1/2 responses to gonadotropin-releasing hormone receptor activation. J. Biol. Chem. 278, 19118-19126.
14. Slomiany, B. L., and Slomiany, A. (2002) Porphyromonas gingivalis lipopolysaccharide interferes with salivary mucin synthesis through inducible nitric oxide synthase activation of ERK and p38 kinase. Biochem. Biophys. Res. Commun. 97, 1149-1153.
15. 15N] nitrate in biological fluids. Anal. Biochem. 126, 131-138.
16. Slomiany, B. L., and Slomiany, A. (2003) Impedance of H. pylori lipopolysaccharide interference with gastric mucin synthesis by peroxisome proliferator-activated receptor γ activation involves phosphatidylinositol 3-kinase/ERK pathway. IUBMB Life 55, 97-102.
17. Orellana, A., Holuigue, L., Hidalgo, P. C., Faundez, V., Gonzalez, A., and Brofman, M. (1993) Ciprofibrate, a carcinogenic peroxisome proliferator, increases the phosphorylation of epidermal-growth-factor receptor in isolated hepatocytes. Er. J. Biochem. 215, 903-906.
18. Yan, Y., Shirakabe, K., and Werb, Z. (2002) The metalloprotease kuzbanian (ADAM 10) mediates the transactivation of EGF receptor by G protein-coupled receptors. J. Cell Biol. 158, 221-226.
19. Zhao, H., Tian, W. C., Tai, C., and Cohen, D. M. (2003) Hypertonic induction of COX-2 expression in renal medullary epithelial cells requires transactivation of the EGFR. Am. J. Physiol. 285, F281-288.